Cargando…
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes
AIMS: In long QT syndrome (LQTS) patients, modifier genes modulate the arrhythmic risk associated with a disease-causing mutation. Their recognition can improve risk stratification and clinical management, but their discovery represents a challenge. We tested whether a cellular-driven approach could...
Autores principales: | Lee, Yee-Ki, Sala, Luca, Mura, Manuela, Rocchetti, Marcella, Pedrazzini, Matteo, Ran, Xinru, Mak, Timothy S H, Crotti, Lia, Sham, Pak C, Torre, Eleonora, Zaza, Antonio, Schwartz, Peter J, Tse, Hung-Fat, Gnecchi, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898949/ https://www.ncbi.nlm.nih.gov/pubmed/32173736 http://dx.doi.org/10.1093/cvr/cvaa019 |
Ejemplares similares
-
Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: The case of hydroxychloroquine in COVID-19
por: Sala, Luca, et al.
Publicado: (2022) -
Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells
por: Sala, Luca, et al.
Publicado: (2019) -
Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19
por: Sala, Luca, et al.
Publicado: (2022) -
Congenital long QT syndrome
por: Crotti, Lia, et al.
Publicado: (2008) -
Congenital Short QT Syndrome
por: Crotti, Lia, et al.
Publicado: (2010)